Literature DB >> 4959828

Antinuclear antibodies following hydralazine toxicity.

J J Condemi, D Moore-Jones, J H Vaughan, H M Perry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4959828     DOI： 10.1056/NEJM196703022760902

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  Prazosin treatment complicated by acute febrile polyarthritis.

Authors:  S A Cairns; S C Jordan
Journal:  Br Med J       Date:  1976-12-11

Review 2.  Immunotoxic side-effects of drug therapy.

Authors:  J A Mitchell; E M Gillam; L A Stanley; E Sim
Journal:  Drug Saf       Date:  1990 May-Jun       Impact factor: 5.606

3.  Studies on drug induced lupus erythematosus in mice. I. Drug induced antinuclear antibodies (ANA).

Authors:  J H ten Veen; T E Feltkamp
Journal:  Clin Exp Immunol       Date:  1972-06       Impact factor: 4.330

4.  Induction by isoniazid and hydrallazine of antinuclear factors in mice.

Authors:  A Cannat; M Seligmann
Journal:  Clin Exp Immunol       Date:  1968-01       Impact factor: 4.330

5.  Drug-induced lupus syndromes.

Authors: 
Journal:  Br Med J       Date:  1970-04-25

6.  Heterogeneity of anti-mitochondrial antibodies: characterization and separation of the antigen associated with the pseudolupus erythematosus syndrome.

Authors:  T J Sayers; T Binder; P A Berg
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

7.  Induction of antibodies to nuclear antigens in rabbits by immunization with hydralazine-human serum albumin conjugates.

Authors:  Y Yamauchi; A Litwin; L Adams; H Zimmer; E V Hess
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

8.  Relationship between deoxyribonucleoprotein and deoxyribonucleic acid antibodies in systemic lupus erythematosus.

Authors:  P Robitaille; E M Tan
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

Review 9.  Antinuclear antibodies and cardiovascular drugs.

Authors:  J D Wilson
Journal:  Drugs       Date:  1980-04       Impact factor: 9.546

10.  Hydralazine, antinuclear antibodies, and the lupus syndrome.

Authors:  R Mansilla-Tinoco; S J Harland; P J Ryan; R M Bernstein; C T Dollery; G R Hughes; C J Bulpitt; A Morgan; J M Jones
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.